Rimonabant PowerPoint PPT Presentations

All Time
Show:
Recommended
Sort by:
Changes in weight and waist size in the rimonabant- and placebo-treated groups PowerPoint PPT Presentation
Changes in weight and waist size in the rimonabant- and placebo-treated groups - Changes in weight and waist size in the rimonabant- and placebo-treated groups p Placebo (n=348) Rimonabant 20 mg (n=339) End point
Changes in weight and waist size in the rimonabant- and placebo-treated groups p Placebo (n=348) Rimonabant 20 mg (n=339) End point
| PowerPoint PPT presentation | free to download
Rimonabant: New therapeutic option for managing cardiometabolic risk PowerPoint PPT Presentation
Rimonabant: New therapeutic option for managing cardiometabolic risk - Increased prevalence of these conditions is projected to have a major impact on ... (CB2) Cannabinoid receptor type 1 (CB1) Immune cells. Most widespread CB receptor ...
Increased prevalence of these conditions is projected to have a major impact on ... (CB2) Cannabinoid receptor type 1 (CB1) Immune cells. Most widespread CB receptor ...
| PowerPoint PPT presentation | free to view
STRADIVARIUS Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesi PowerPoint PPT Presentation
STRADIVARIUS Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesi - PAV: primary endpoint. TAV: secondary endpoint -2.2. 0.88. 0.51. 0.25. P 0. ... for rimonabant on the primary endpoint, PAV (P = 0.22), but a favorable effect ...
PAV: primary endpoint. TAV: secondary endpoint -2.2. 0.88. 0.51. 0.25. P 0. ... for rimonabant on the primary endpoint, PAV (P = 0.22), but a favorable effect ...
| PowerPoint PPT presentation | free to view
Sesin Bibliogrfica 2513 Rimonabant un bloqueante de los receptores de canabinoides1 y dieta inducen PowerPoint PPT Presentation
Sesin Bibliogrfica 2513 Rimonabant un bloqueante de los receptores de canabinoides1 y dieta inducen - Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J. Effect of ... de rimonabant a placebo volvieron a ganar peso, mientras que los que siguieron ...
Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J. Effect of ... de rimonabant a placebo volvieron a ganar peso, mientras que los que siguieron ...
| PowerPoint PPT presentation | free to view
Presentazione di PowerPoint PowerPoint PPT Presentation
Presentazione di PowerPoint - ... 299:1547-60 Effects of Rimonabant on Body Weight, Waist Circumference, and Levels of HDL-C, Triglycerides, Fasting Insulin, and Glycated Hemoglobin ...
... 299:1547-60 Effects of Rimonabant on Body Weight, Waist Circumference, and Levels of HDL-C, Triglycerides, Fasting Insulin, and Glycated Hemoglobin ...
| PowerPoint PPT presentation | free to download
Clinical evaluation of CB1 receptor blockade PowerPoint PPT Presentation
Clinical evaluation of CB1 receptor blockade - Clinical evaluation of CB1 receptor blockade Rimonabant clinical trial program Rimonabant In Obesity (RIO) program RIO program: Improved cardiometabolic risk factors ...
Clinical evaluation of CB1 receptor blockade Rimonabant clinical trial program Rimonabant In Obesity (RIO) program RIO program: Improved cardiometabolic risk factors ...
| PowerPoint PPT presentation | free to download
Presentazione di PowerPoint PowerPoint PPT Presentation
Presentazione di PowerPoint - ... 353: 2121-34 Effect of Placebo or 20 mg of Rimonabant for 52 Weeks on the Plasma Glucose and Insulin Responses to Oral Glucose Challenge (Panels A - B), ...
... 353: 2121-34 Effect of Placebo or 20 mg of Rimonabant for 52 Weeks on the Plasma Glucose and Insulin Responses to Oral Glucose Challenge (Panels A - B), ...
| PowerPoint PPT presentation | free to download
Cannabinoid CB1 receptor PowerPoint PPT Presentation
Cannabinoid CB1 receptor - ... Highest conc in hippo, striatum, ctx and cerebellum THC acts as CB1 agonist Some diet drugs act as CB1 antagonist Rimonabant (aka SR141716) ...
... Highest conc in hippo, striatum, ctx and cerebellum THC acts as CB1 agonist Some diet drugs act as CB1 antagonist Rimonabant (aka SR141716) ...
| PowerPoint PPT presentation | free to download
Catheter Ablation for the Cure of Atrial Fibrillation Study PowerPoint PPT Presentation
Catheter Ablation for the Cure of Atrial Fibrillation Study - Among patients with paroxysmal or persistent atrial fibrillation who have already failed antiarrhythmic ... with antiarrhythmic drug ... Rimonabant in Obesity ...
Among patients with paroxysmal or persistent atrial fibrillation who have already failed antiarrhythmic ... with antiarrhythmic drug ... Rimonabant in Obesity ...
| PowerPoint PPT presentation | free to download
Diapositive 1 PowerPoint PPT Presentation
Diapositive 1 - R duire les dommages de l'hyperglyc mie. R duire les autres facteurs ... ANTAGONISTES DES RECEPTEURS CB1. Rimonabant. Effets centraux. Effets p riph riques. Prise ...
R duire les dommages de l'hyperglyc mie. R duire les autres facteurs ... ANTAGONISTES DES RECEPTEURS CB1. Rimonabant. Effets centraux. Effets p riph riques. Prise ...
| PowerPoint PPT presentation | free to download
Data Supplement PowerPoint PPT Presentation
Data Supplement - Arthralgia. 9. Dizziness. 12. Nasopharyngitis. 12. Nausea. Rimonabant 20 mg (%) (n = 339) ... Arthralgia. 11.2. Nausea. 17.0. Nasopharyngitis. 18.5. URTI ...
Arthralgia. 9. Dizziness. 12. Nasopharyngitis. 12. Nausea. Rimonabant 20 mg (%) (n = 339) ... Arthralgia. 11.2. Nausea. 17.0. Nasopharyngitis. 18.5. URTI ...
| PowerPoint PPT presentation | free to view
Diabetes Primary Care Study Day New NICE Guidance on Lipids: General 67 and Diabetes 66 Wiltshire Mu PowerPoint PPT Presentation
Diabetes Primary Care Study Day New NICE Guidance on Lipids: General 67 and Diabetes 66 Wiltshire Mu - Rimonabant. NNTs. JBS2 - targets. Total Cholesterol 4 and. LDL Cholesterol 2. OR ... Limits cholesterol absorption by specific effect on transport. Few side-effects ...
Rimonabant. NNTs. JBS2 - targets. Total Cholesterol 4 and. LDL Cholesterol 2. OR ... Limits cholesterol absorption by specific effect on transport. Few side-effects ...
| PowerPoint PPT presentation | free to view
Patients views PowerPoint PPT Presentation
Patients views - Patients prescribed either orlistat, sibutramine, rimonabant in the last 2 years ... loss in the short-term adapted to medication regime & managed side effects ' ...
Patients prescribed either orlistat, sibutramine, rimonabant in the last 2 years ... loss in the short-term adapted to medication regime & managed side effects ' ...
| PowerPoint PPT presentation | free to view
Weight loss tablets PowerPoint PPT Presentation
Weight loss tablets - Find weight loss tablets with affordable price.
Find weight loss tablets with affordable price.
| PowerPoint PPT presentation | free to download
Presentazione di PowerPoint PowerPoint PPT Presentation
Presentazione di PowerPoint - Title: Presentazione di PowerPoint Author: Walter Fratta Last modified by: Engius Created Date: 5/23/2002 4:29:51 PM Document presentation format
Title: Presentazione di PowerPoint Author: Walter Fratta Last modified by: Engius Created Date: 5/23/2002 4:29:51 PM Document presentation format
| PowerPoint PPT presentation | free to download
Data Supplement PowerPoint PPT Presentation
Data Supplement - Data Supplement RIO-Europe RIO-Lipids RIO-Diabetes RIO-North America European labeling
Data Supplement RIO-Europe RIO-Lipids RIO-Diabetes RIO-North America European labeling
| PowerPoint PPT presentation | free to view
Pharmacy Dropship PowerPoint PPT Presentation
Pharmacy Dropship - Best Pharmcy Dropshiping services from india.
Best Pharmcy Dropshiping services from india.
| PowerPoint PPT presentation | free to download
Journal Club PowerPoint PPT Presentation
Journal Club - Biliopancreatic diversion Roux-en-Y gastric bypass Sleeve gastrectomy with duodenal switch Adjustable gastric banding ... laparoscopic adjustable gastric ...
Biliopancreatic diversion Roux-en-Y gastric bypass Sleeve gastrectomy with duodenal switch Adjustable gastric banding ... laparoscopic adjustable gastric ...
| PowerPoint PPT presentation | free to download
Obesity Treatment Pyramid PowerPoint PPT Presentation
Obesity Treatment Pyramid - The Practical Guide: Identification, Evaluation, and Treatment of Overweight and ... Exenatide (Byetta); incretin mimetic. Enhances insulin secretion ...
The Practical Guide: Identification, Evaluation, and Treatment of Overweight and ... Exenatide (Byetta); incretin mimetic. Enhances insulin secretion ...
| PowerPoint PPT presentation | free to view
Top 10 Cannabis Based Pharmaceutical Drugs PowerPoint PPT Presentation
Top 10 Cannabis Based Pharmaceutical Drugs - Medical marijuana comes in many different forms. You may be surprised to know that there is various cannabis based pharmaceutical drugs in the market.
Medical marijuana comes in many different forms. You may be surprised to know that there is various cannabis based pharmaceutical drugs in the market.
| PowerPoint PPT presentation | free to download
E-mail: itlambev@mail.bg PowerPoint PPT Presentation
E-mail: itlambev@mail.bg - Title: No Slide Title Author: Ivan Lambev Last modified by: Owner Created Date: 4/12/1999 12:15:04 PM Document presentation format: On-screen Show Other titles
Title: No Slide Title Author: Ivan Lambev Last modified by: Owner Created Date: 4/12/1999 12:15:04 PM Document presentation format: On-screen Show Other titles
| PowerPoint PPT presentation | free to download
Cannabinoid CB1 ligands PowerPoint PPT Presentation
Cannabinoid CB1 ligands - Cannabinoid CB1 ligands. LY 320135. CB1 antagonist. AM251. CB1 ... Acomplia, CB1 antagonist. CP-55940. Mixed CB1/CB2 agonist. HU-210. Mixed CB1/CB2 agonist ...
Cannabinoid CB1 ligands. LY 320135. CB1 antagonist. AM251. CB1 ... Acomplia, CB1 antagonist. CP-55940. Mixed CB1/CB2 agonist. HU-210. Mixed CB1/CB2 agonist ...
| PowerPoint PPT presentation | free to view
Diet%20Pills PowerPoint PPT Presentation
Diet%20Pills - Diet Pills. By Cathy Chang. Article ... and suicide in patients taking the diet pill. ... Why do you think that people would prefer to take diet pills? ...
Diet Pills. By Cathy Chang. Article ... and suicide in patients taking the diet pill. ... Why do you think that people would prefer to take diet pills? ...
| PowerPoint PPT presentation | free to download
Managing HbA1c and CRP in a hypertensive diabetic patient PowerPoint PPT Presentation
Managing HbA1c and CRP in a hypertensive diabetic patient - ... New therapies GLP1 analogs Exenitide GLP1-degradation blockers Dipeptidyl peptidase 4 (DPP4) inhibitors Sitagliptin Vildagliptin Weight and diabetes: ...
... New therapies GLP1 analogs Exenitide GLP1-degradation blockers Dipeptidyl peptidase 4 (DPP4) inhibitors Sitagliptin Vildagliptin Weight and diabetes: ...
| PowerPoint PPT presentation | free to view
Marco Lo Dico Ugo Perricone PowerPoint PPT Presentation
Marco Lo Dico Ugo Perricone - Etat caract ris par un exc s de masse adipeuse repartie de fa on g n ralis e ... En agissant sur les canaux du calcium, donc sur la concentration du Ca ...
Etat caract ris par un exc s de masse adipeuse repartie de fa on g n ralis e ... En agissant sur les canaux du calcium, donc sur la concentration du Ca ...
| PowerPoint PPT presentation | free to view
Obesity Treatment Pyramid PowerPoint PPT Presentation
Obesity Treatment Pyramid - Obesity Treatment Pyramid Surgery Pharmacotherapy Lifestyle Modification Diet Physical Activity Guide for Selecting Obesity Treatment Obesity and Dietary Therapy ...
Obesity Treatment Pyramid Surgery Pharmacotherapy Lifestyle Modification Diet Physical Activity Guide for Selecting Obesity Treatment Obesity and Dietary Therapy ...
| PowerPoint PPT presentation | free to view
ACTIVE PHARMACEUTICAL INGREDIENTS FROM DEV LIFE CORPORATION PowerPoint PPT Presentation
ACTIVE PHARMACEUTICAL INGREDIENTS FROM DEV LIFE CORPORATION - ... asthmatic / bronchodilator montelukast sodium roflumilast salmeterol xinafoate zafirlukast anti hypertensive eplerenone ... powerpoint presentation ...
... asthmatic / bronchodilator montelukast sodium roflumilast salmeterol xinafoate zafirlukast anti hypertensive eplerenone ... powerpoint presentation ...
| PowerPoint PPT presentation | free to download
MEDICAL MANAGEMENT OF OBESITY Selected Topics PowerPoint PPT Presentation
MEDICAL MANAGEMENT OF OBESITY Selected Topics - MEDICAL MANAGEMENT OF OBESITY Selected Topics Patient evaluation Diet Exercise Obesity medications * CNTF: endogenous neuroprotective factor in Schwann cells and ...
MEDICAL MANAGEMENT OF OBESITY Selected Topics Patient evaluation Diet Exercise Obesity medications * CNTF: endogenous neuroprotective factor in Schwann cells and ...
| PowerPoint PPT presentation | free to download
Dyslipidemia in the Metabolic Syndrome: Can 1 agent treat all? PowerPoint PPT Presentation
Dyslipidemia in the Metabolic Syndrome: Can 1 agent treat all? - Dyslipidemia in the Metabolic Syndrome: Can 1 agent treat all? Brian Tulloch, M.D. Diagnostic Clinic Houston, Texas
Dyslipidemia in the Metabolic Syndrome: Can 1 agent treat all? Brian Tulloch, M.D. Diagnostic Clinic Houston, Texas
| PowerPoint PPT presentation | free to download
St PowerPoint PPT Presentation
St - 1988 High-affinity cannabinoid binding sites were discovered in rat brain ... Inhibition of neurotransmitter release is blocked by antagonists of CB1 receptor. ...
1988 High-affinity cannabinoid binding sites were discovered in rat brain ... Inhibition of neurotransmitter release is blocked by antagonists of CB1 receptor. ...
| PowerPoint PPT presentation | free to view
Obesity : the new health issue Overview of therapeutics in the area Dr Richard Palmer CEO and R PowerPoint PPT Presentation
Obesity : the new health issue Overview of therapeutics in the area Dr Richard Palmer CEO and R - Prevalence of Adult Obesity in Europe BMI 30 Kgm2 ... Insulin enhancer. Pramlintide. Alizyme. Lipase inhibitor. Cetilistat. Sanofi-Aventis. CB1 antagonist ...
Prevalence of Adult Obesity in Europe BMI 30 Kgm2 ... Insulin enhancer. Pramlintide. Alizyme. Lipase inhibitor. Cetilistat. Sanofi-Aventis. CB1 antagonist ...
| PowerPoint PPT presentation | free to view
Abdominal Obesity and Cardiometabolic Risk: The Role of the Endocannabinoid System PowerPoint PPT Presentation
Abdominal Obesity and Cardiometabolic Risk: The Role of the Endocannabinoid System - Gout. Cholecystitis. Colon (?Breast) Cancers ... Gout. Gall Bladder. Disease. Some Cancers. What Is Cardiometabolic Risk? Diabetes: A Genetic Legacy ...
Gout. Cholecystitis. Colon (?Breast) Cancers ... Gout. Gall Bladder. Disease. Some Cancers. What Is Cardiometabolic Risk? Diabetes: A Genetic Legacy ...
| PowerPoint PPT presentation | free to view
Obesity PowerPoint PPT Presentation
Obesity - Biochemistry
Biochemistry
| PowerPoint PPT presentation | free to download
of atherosclerosis in patients with abdominal obesity an PowerPoint PPT Presentation
of atherosclerosis in patients with abdominal obesity an - of atherosclerosis in patients with abdominal obesity and coronary artery disease ... Abdominal obesity is associated with specific metabolic abnormalities that ...
of atherosclerosis in patients with abdominal obesity and coronary artery disease ... Abdominal obesity is associated with specific metabolic abnormalities that ...
| PowerPoint PPT presentation | free to view
New Pharmacotherapies for Assisting Smokers in Their Cessation Efforts- Update PowerPoint PPT Presentation
New Pharmacotherapies for Assisting Smokers in Their Cessation Efforts- Update - Title: PowerPoint Presentation Author: Anne Quito Last modified by: Aed_User Created Date: 11/16/2005 4:14:20 PM Document presentation format: On-screen Show
Title: PowerPoint Presentation Author: Anne Quito Last modified by: Aed_User Created Date: 11/16/2005 4:14:20 PM Document presentation format: On-screen Show
| PowerPoint PPT presentation | free to download
Scientific Writing, HRP 214 Weekly Quiz PowerPoint PPT Presentation
Scientific Writing, HRP 214 Weekly Quiz - Title: Science Writing 7 Author: Kristin Cobb Last modified by: Kristin Created Date: 5/17/1996 12:08:30 PM Document presentation format: Letter Paper (8.5x11 in)
Title: Science Writing 7 Author: Kristin Cobb Last modified by: Kristin Created Date: 5/17/1996 12:08:30 PM Document presentation format: Letter Paper (8.5x11 in)
| PowerPoint PPT presentation | free to download
Diabetologie: Was ist neu seit 2005? PowerPoint PPT Presentation
Diabetologie: Was ist neu seit 2005? - Diabetologie: Was ist neu seit 2005? https://www2.univadis.de/academia/?section=symposien&study=symp00022
Diabetologie: Was ist neu seit 2005? https://www2.univadis.de/academia/?section=symposien&study=symp00022
| PowerPoint PPT presentation | free to download
TISSU ADIPEUX VISCERAL CIBL UNE NOUVELLE OPTION DE LA BITHERAPIE ORALE PowerPoint PPT Presentation
TISSU ADIPEUX VISCERAL CIBL UNE NOUVELLE OPTION DE LA BITHERAPIE ORALE - TISSU ADIPEUX VISCERAL CIBL UNE NOUVELLE OPTION DE LA BITHERAPIE ORALE
TISSU ADIPEUX VISCERAL CIBL UNE NOUVELLE OPTION DE LA BITHERAPIE ORALE
| PowerPoint PPT presentation | free to download
How To Become Slim Again With Natural Supplements? PowerPoint PPT Presentation
How To Become Slim Again With Natural Supplements? - This Power Point Presentation describes about How To Become Slim Again With Natural Supplements.
This Power Point Presentation describes about How To Become Slim Again With Natural Supplements.
| PowerPoint PPT presentation | free to download
Diapositiva 1 PowerPoint PPT Presentation
Diapositiva 1 - Cannabinoides e inflamaci n intestinal ANANDAMIDA ( concentraci n) CB-1 CB-2 TRPV-1 Inflamaci n Contractilidad Hipersecreci n Cicatrizaci n
Cannabinoides e inflamaci n intestinal ANANDAMIDA ( concentraci n) CB-1 CB-2 TRPV-1 Inflamaci n Contractilidad Hipersecreci n Cicatrizaci n
| PowerPoint PPT presentation | free to download
Obesidad PowerPoint PPT Presentation
Obesidad - Cruz Contreras (Luis Humberto) Estado de exceso de masa de tejido adiposo IMC (kg/m2), antropometr a (pliegues cut neos, densitometr a, CT, MRI q.
Cruz Contreras (Luis Humberto) Estado de exceso de masa de tejido adiposo IMC (kg/m2), antropometr a (pliegues cut neos, densitometr a, CT, MRI q.
| PowerPoint PPT presentation | free to download
Molecular and Clinical Nutrition Course PowerPoint PPT Presentation
Molecular and Clinical Nutrition Course - Calorie intake must be less than caloric ... Calorie Controlled portions. ... Over-The Counter Orlistat Alli Rossner S et al. Obes Res 8(1):49-60, 2000. ...
Calorie intake must be less than caloric ... Calorie Controlled portions. ... Over-The Counter Orlistat Alli Rossner S et al. Obes Res 8(1):49-60, 2000. ...
| PowerPoint PPT presentation | free to view
Dr Nicki Mazey PowerPoint PPT Presentation
Dr Nicki Mazey - Obesity Primary Care Management Dr Nicki Mazey Introduction Predisposing factors Co-morbidities Managing Obesity in primary care Sleep apnoea/Binge eating Tools ...
Obesity Primary Care Management Dr Nicki Mazey Introduction Predisposing factors Co-morbidities Managing Obesity in primary care Sleep apnoea/Binge eating Tools ...
| PowerPoint PPT presentation | free to view
New Pharmacotherapies for Assisting Smokers in Their Cessation Efforts PowerPoint PPT Presentation
New Pharmacotherapies for Assisting Smokers in Their Cessation Efforts - Weight gain in the 20 mg group was 0.4 kg for 12 weeks versus 3.6 kg for placebo ... May be sought after by smokers who want to quit but don't want to gain weight ...
Weight gain in the 20 mg group was 0.4 kg for 12 weeks versus 3.6 kg for placebo ... May be sought after by smokers who want to quit but don't want to gain weight ...
| PowerPoint PPT presentation | free to download
Medicines for the Treatment of Obesity PowerPoint PPT Presentation
Medicines for the Treatment of Obesity - Medicines for the Treatment of Obesity But Doc, isn t there a pill I can take? Joanna Ruchala, MD Outline Case Presentation Definition, Prevalence ...
Medicines for the Treatment of Obesity But Doc, isn t there a pill I can take? Joanna Ruchala, MD Outline Case Presentation Definition, Prevalence ...
| PowerPoint PPT presentation | free to view
Women @ Heart The link between visceral fat and Athersclerosis PowerPoint PPT Presentation
Women @ Heart The link between visceral fat and Athersclerosis - Women @ Heart The link between visceral fat and Athersclerosis By Ashraf Reda MD Prof and Head of Cardiology Dep Menofia university Effect of plasma FFA Lipid profile ...
Women @ Heart The link between visceral fat and Athersclerosis By Ashraf Reda MD Prof and Head of Cardiology Dep Menofia university Effect of plasma FFA Lipid profile ...
| PowerPoint PPT presentation | free to download
CVD Critical Pathways Group 2006 Teleconferences PowerPoint PPT Presentation
CVD Critical Pathways Group 2006 Teleconferences - The Network for Continuing Medical Education requires that ... Phentermine. Year Approved. Approved Use. DEA Schedule. 1997. Long term. IV. 1973. Short term ...
The Network for Continuing Medical Education requires that ... Phentermine. Year Approved. Approved Use. DEA Schedule. 1997. Long term. IV. 1973. Short term ...
| PowerPoint PPT presentation | free to view
RIOLipids: Treatment effect on lipids PowerPoint PPT Presentation
RIOLipids: Treatment effect on lipids - RIO-Lipids: Treatment effect on lipids. Despr s J-P et al. N Engl J Med. 2005;353:2121-34. ... Intent-to-treat population *P 0.001 vs placebo. No significant ...
RIO-Lipids: Treatment effect on lipids. Despr s J-P et al. N Engl J Med. 2005;353:2121-34. ... Intent-to-treat population *P 0.001 vs placebo. No significant ...
| PowerPoint PPT presentation | free to view
AntiObesity Medication PowerPoint PPT Presentation
AntiObesity Medication - Should not be prescribed to children in General Practice if all other advice ... Benefit in taking BP and blood for fasting glc and lipid profile ...
Should not be prescribed to children in General Practice if all other advice ... Benefit in taking BP and blood for fasting glc and lipid profile ...
| PowerPoint PPT presentation | free to view
Obesity Pharmacological treatments PowerPoint PPT Presentation
Obesity Pharmacological treatments - A low energy,low fat diet is the most effective lifestyle intervention for weight loss ... Flatulence. Fatty oily stools. Faecal urgency ...
A low energy,low fat diet is the most effective lifestyle intervention for weight loss ... Flatulence. Fatty oily stools. Faecal urgency ...
| PowerPoint PPT presentation | free to view
Metabolic Syndrome, Diabetes, and Cardiovascular Disease: Implications for Preventive Cardiology PowerPoint PPT Presentation
Metabolic Syndrome, Diabetes, and Cardiovascular Disease: Implications for Preventive Cardiology - Abdominal obesity is more highly correlated with metabolic risk factors than is ... Obesity / weight management: low fat high fiber diet resulting in 500-1000 ...
Abdominal obesity is more highly correlated with metabolic risk factors than is ... Obesity / weight management: low fat high fiber diet resulting in 500-1000 ...
| PowerPoint PPT presentation | free to view
Largest Single Cost for Medicare PowerPoint PPT Presentation
Largest Single Cost for Medicare - Charles P. O'Brien, MD, PhD. University of Pennsylvania ... Wade Berrettini A. Thomas McLellan. John Cacciola David Metzger. Anna Rose Childress David Oslin ...
Charles P. O'Brien, MD, PhD. University of Pennsylvania ... Wade Berrettini A. Thomas McLellan. John Cacciola David Metzger. Anna Rose Childress David Oslin ...
| PowerPoint PPT presentation | free to view
Ting-Kai Li, M.D. PowerPoint PPT Presentation
Ting-Kai Li, M.D. - National Institute on Alcohol Abuse and Alcoholism ... National Institute on Alcohol Abuse and Alcoholism. ??????????:????30??????5?????5???? ...
National Institute on Alcohol Abuse and Alcoholism ... National Institute on Alcohol Abuse and Alcoholism. ??????????:????30??????5?????5???? ...
| PowerPoint PPT presentation | free to download
Whatever happened to the lifestyle drugs PowerPoint PPT Presentation
Whatever happened to the lifestyle drugs - Health Chiefs Ban Too Costly' Viagra. Daily Mirror 13/9/98 ... Viagra's First Flop. The Mirror 15/9/98. Obesity Pill May Add to NHS Budget Strain ...
Health Chiefs Ban Too Costly' Viagra. Daily Mirror 13/9/98 ... Viagra's First Flop. The Mirror 15/9/98. Obesity Pill May Add to NHS Budget Strain ...
| PowerPoint PPT presentation | free to view
Evidence Supporting Aggressive Glycemic Control PowerPoint PPT Presentation
Evidence Supporting Aggressive Glycemic Control - Evidence Supporting Aggressive Glycemic Control
Evidence Supporting Aggressive Glycemic Control
| PowerPoint PPT presentation | free to view


Home About Us Terms and Conditions Privacy Policy Contact Us
Copyright 2024 CrystalGraphics, Inc. — All rights Reserved. PowerShow.com is a trademark of CrystalGraphics, Inc.
rimonabant — Search results on PowerShow.com